These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24780825)

  • 1. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
    Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
    Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
    Bruch PG; Plage H; Hofbauer S; Kornienko K; Weinberger S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Zecha H; Klatte T; Schlomm T; Horst D; Elezkurtaj S
    Exp Mol Pathol; 2023 Jun; 131():104860. PubMed ID: 36997051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
    So JS; Epstein JI
    Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
    Buza N; Cohen PJ; Pei Hui ; Parkash V
    Int J Surg Pathol; 2010 Apr; 18(2):94-102. PubMed ID: 20164052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
    Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
    Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of GATA-3 in urothelial carcinoma variants.
    Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
    Sanfrancesco J; McKenney JK; Leivo MZ; Gupta S; Elson P; Hansel DE
    Arch Pathol Lab Med; 2016 Jun; 140(6):543-51. PubMed ID: 27031776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
    Sledge DG; Patrick DJ; Fitzgerald SD; Xie Y; Kiupel M
    Vet Pathol; 2015 Jan; 52(1):74-82. PubMed ID: 24608632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.
    Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS
    Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
    Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE
    Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.
    Li W; Liang Y; Deavers MT; Kamat AM; Matin SF; Dinney CP; Czerniak B; Guo CC
    Am J Clin Pathol; 2014 Dec; 142(6):864-71. PubMed ID: 25389341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
    Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
    J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy.
    Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A
    Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes.
    Portugal-Gaspar F; Lopez-Beltran A; Paner GP; Blanca A; Gómez EG; Montironi R; Cimadamore A; Bilé A; Volavšek M; Cheng L
    Virchows Arch; 2024 Sep; 485(3):535-546. PubMed ID: 39023556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.